Quantitation of human metallothionein isoforms: a family of small, highly conserved, cysteine-rich proteins.
Human metallothioneins (MTs) are important regulators of metal homeostasis and protectors against oxidative damage. Their altered mRNA expression has been correlated with metal toxicity and a variety of cancers. Current immunodetection methods lack the specificity to distinguish all 12 human isoforms. Each, however, can be distinguished by the mass of its acetylated, cysteine-rich, hydrophilic N-terminal tryptic peptides. These properties were exploited to develop a bottom-up MALDI-TOF/TOF-MS-based method for their simultaneous quantitation. Key features included enrichment of N-terminal acetylated peptides by strong cation exchange chromatography, optimization of C18 reversed-phase chromatography, and control of methionine oxidation. Combinations of nine isoforms were identified in seven cell lines and two tissues. Relative quantitation was accomplished by comparing peak intensities of peptides generated from pooled cytosolic proteins alkylated with ¹⁴N- or ¹⁵N-iodoacetamide. Absolute quantitation was achieved using ¹⁵N-iodoacetamide-labeled synthetic peptides as internal standards. The method was applied to the cadmium induction of MTs in human kidney HK-2 epithelial cells expressing recombinant MT-3. Seven isoforms were detected with abundances spanning almost 2 orders of magnitude and inductions up to 12-fold. The protein-to-mRNA ratio for MT-1E was one-tenth that of other MTs, suggesting isoform-specific differences in protein expression efficiency. Differential expression of MT-1G1 and MT-1G2 suggested tissue- and cell-specific alternative splicing for the MT-1G isoform. Protein expression of MT isoforms was also evaluated in human breast epithelial cancer cell lines. Estrogen-receptor-positive cell lines expressed only MT-2 and MT-1X, whereas estrogen-receptor-negative cell lines additionally expressed MT-1E. The combined expression of MT isoforms was 38-fold greater in estrogen-receptor-negative cell lines than in estrogen-receptor-positive cells. These findings demonstrate that individual human MT isoforms can be accurately quantified in cells and tissues at the protein level, complementing and expanding mRNA measurement as a means for evaluating MTs as potential biomarkers for cancers or heavy metal toxicity.
Department of Basic Sciences, School of Medicine and Health Sciences, University of North Dakota, 501 Columbia Road N., Grand Forks, North Dakota 58203;
Aaron A
AA
Mehus
Wallace W
WW
Muhonen
Scott H
SH
Garrett
Seema
S
Somji
Donald A
DA
Sens
John B
JB
Shabb
D017398:Alternative Splicing; D001943:Breast Neoplasms / Q000378:metabolism*; D002104:Cadmium / Q000494:pharmacology; D002478:Cells, Cultured; D054022:Cerebrum / Q000378:metabolism*; D003545:Cysteine / Q000737:chemistry; D003600:Cytosol / Q000378:metabolism; D004847:Epithelial Cells / Q000378:metabolism; D005260:Female; D006801:Humans; D007668:Kidney / Q000166:cytology / Q000378:metabolism*; D061986:MCF-7 Cells; D008668:Metallothionein / Q000032:analysis* / Q000737:chemistry / Q000378:metabolism; D008715:Methionine / Q000378:metabolism; D009928:Organ Specificity; D010455:Peptides / Q000032:analysis / Q000737:chemistry; D020033:Protein Isoforms / Q000032:analysis / Q000737:chemistry / Q000378:metabolism; D040901:Proteomics; D015203:Reproducibility of Results; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization / Q000379:methods*
D010455:Peptides; D020033:Protein Isoforms; D002104:Cadmium; D008668:Metallothionein; D008715:Methionine; D003545:Cysteine